Corindus Vascular Robotics: robotics company

Overview

Robotic vascular intervention company. Acquired by Siemens Healthineers for ~$1.1B (2019). Product: CorPath system — first FDA-cleared robotic-assisted vascular intervention platform. Enabled remote-controlled precision for PCI, peripheral vascular, and neurovascular procedures. $100M+ total raised before acquisition.

Verified record

Verified deployments: None on file
Active incidents: None on file

Key facts

Product

CorPath — FDA-cleared robotic vascular intervention platform

Acquisition

Siemens Healthineers ~$1.1B (2019)

Total Fundingsee investors →

$100M+ pre-acquisition

Status

Acquired — now Siemens Healthineers Corindus

Data & sources

Patent documents

2

Web sources

1

3 sources backing this record.View all →

Corindus Vascular Robotics on the deployment map

View the global map

Corindus Vascular Robotics has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

The global deployment map →

No verified deployments for Corindus Vascular Robotics on the DEPLOY record yet. Track Corindus Vascular Robotics to know the moment the first one is verified.

Safety record

No incidents on record for Corindus Vascular Robotics.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Corindus Vascular Robotics in third-party press

Microbot receives 510(k) clearance for endovascular robot - MedTech Dive

Sep 9, 2025

Siemens Calls It Quits in Cardiovascular Surgical Robotics - Medical Device and Diagnostic industry

May 10, 2023

Siemens Healthineers' Corindus surgical robot clears brain aneurysm study - Fierce Biotech

Sep 12, 2022

Patent estate (2)

US7646161B2usptograntedgranted 2010-01-12assignee
US7689320B2usptograntedgranted 2010-03-30assignee

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Record createdJul 22, 2026
Added to the verified registry

Full change history →

Sources (1)

https://etd.ohiolink.edu/acprod/odb_etd/ws/send_file/send?accession=case1618854255867602

Common questions

What is Corindus Vascular Robotics?

Robotic vascular intervention company. Acquired by Siemens Healthineers for ~$1.1B (2019). Product: CorPath system — first FDA-cleared robotic-assisted vascular intervention platform. Enabled remote-controlled precision for PCI, peripheral vascular, and neurovascular procedures. $100M+ total raised before acquisition.

What does Corindus Vascular Robotics make?

Corindus Vascular Robotics has no robot models recorded on the DEPLOY registry. Corindus Vascular Robotics builds physical robots.

Is Corindus Vascular Robotics publicly traded?

Corindus Vascular Robotics is not an independent public company; it has been acquired, per the DEPLOY registry.

How can I invest in Corindus Vascular Robotics?

Corindus Vascular Robotics has no separately traded stock; it has been acquired.

Where is Corindus Vascular Robotics headquartered?

Corindus Vascular Robotics is headquartered in USA.

Who owns Corindus Vascular Robotics?

Corindus Vascular Robotics has been acquired and is no longer independently owned.

Is Corindus Vascular Robotics a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Corindus Vascular Robotics ranks in roughly the top 41% of companies tracked by the registry.

Is Corindus Vascular Robotics safe?

Corindus Vascular Robotics has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-05

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-05

Sources by quality tier

1: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

<a…

↗

Machine-readable surfaces

Markdown mirror: /companies/corindus.md
RSS feed: /companies/corindus/feed.xml
JSON-LD: embedded in this page’s head
REST API: /v1/companies/9974f113-1cb6-43eb-9ff6-3b07dcbba0d8
Revision history: /companies/corindus/history
Data documentation: /data
Query this programmatically: Deploy MCP

Reality vs attention

Not enough verified signal yet to place Corindus Vascular Robotics against peers. Reality and attention percentiles publish once the underlying record clears its data floor.

6-month trend

Peer rankingTop 41% of category

vs funding peers-20.1 ptsbelow funding-adj. expected

Analysis

Limited public visibility and press coverage relative to peers.

Dimension breakdown

Verified signal

Insufficient data

Insufficient data

Insufficient data

Insufficient data

Insufficient data

Attention (reach, not merit)

Market Presence →

16.516.5HIGH

DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.

DEPLOY Indices — verified vs claimed

Claim Integrity Fleet Reality Operator Repeat All indices

Last computed: Aug 9, 2026

Methodology Intelligence layer